Welcome to LookChem.com Sign In|Join Free

CAS

  • or

51627-76-0

Post Buying Request

51627-76-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

51627-76-0 Usage

Structure

Bicyclic organic compound containing a nitrogen atom.

Usage

Commonly used as a building block in the synthesis of various pharmaceuticals and agrochemicals.

Importance

Unique bicyclic structure and the presence of a nitrile group make it a valuable intermediate in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 51627-76-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,1,6,2 and 7 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 51627-76:
(7*5)+(6*1)+(5*6)+(4*2)+(3*7)+(2*7)+(1*6)=120
120 % 10 = 0
So 51627-76-0 is a valid CAS Registry Number.
InChI:InChI=1/C8H12N2/c9-5-8-6-10-3-1-7(8)2-4-10/h7-8H,1-4,6H2

51627-76-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-azabicyclo[2.2.2]octane-3-carbonitrile

1.2 Other means of identification

Product number -
Other names quinuclidine-3-carbonitrile

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:51627-76-0 SDS

51627-76-0Relevant articles and documents

Synthesis and in vitro muscarinic activities of a series of 3-(pyrazol- 3-yl)-1-azabicyclo[2.2.2]octanes

Plate, Ralf,Plaum, Marc J. M.,Hulst, Rob G. A. V. D.,De Boer, Thijs

, p. 449 - 454 (2000)

A series of 3-(pyrazol-3-yl)-1-azabicyclo[2.2.2]octane derivatives C (Fig. 1) was synthesized and tested for muscarinic activity in receptor binding assays using [3H]-oxotremorine-M (OXO-M) and [3H]-pirenzepine (PZ) as ligands. Potential muscarinic agonistic or antagonistic properties of the compounds were determined using binding studies measuring their potencies to inhibit the binding of OXO-M and PZ. Preferential inhibition of OXO-M binding was used as an indicator for potential muscarinic agonistic properties; this potential was confirmed in functional studies on isolated organs. (C) 2000 Elsevier Science Ltd.

N-biarylamides

-

, (2008/06/13)

The invention relates to N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improvement in cognition, concentration power, learning power and/or memory.

N-BIARYLAMIDES

-

Page/Page column 18, (2008/06/13)

The invention relates to N-biarylamides, methods for production and use thereof for the production of medicaments for the treatment and/or prophylaxis of diseases and for improvement in cognition, concentration power, learning power and/or memory.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 51627-76-0